PURPOSE OF THE STUDY. To determine the association between the 17q12-q21 locus and various clinical characteristics of asthma and atopic sensitization during childhood. STUDY POPULATION. The Copenhagen Prospective Study on Asthma in Childhood (COPSAC) included a birth cohort of 411 children born to mothers with a history of asthma. Three hundred seventy-six of these children underwent genotyping for a particular, single-nucleotide polymorphism (SNP), rs7216389, in the 17q12-q21 locus.
METHODS. Three hundred seventy-six children underwent genotyping for 20 SNPs, including rs7216389. Infants were enrolled at age 1 month and were seen once every 6 months until age 6 years. Parents recorded daily symptoms. End points included investigator-diagnosed asthma or atopic disease and objective measurements of lung function and atopic sensitization, at various follow-up points.
RESULTS. Homozygosity for the T allele at SNP rs7216389 was associated with experiencing wheezing (hazard ratio [HR]: 1.64 [95% confidence interval [CI]: 1.05-2.59]), asthma (HR: 1.88 [95% CI: 1.15-3.07]), and acute severe exacerbations (HR: 2.66 [95% CI: 1.58 -4.48]). Significantly increased bronchial hyperresponsiveness was seen at ages 1 month and 4 years but not 6 years. However, increased risk of asthma exacerbations persisted through age 6 years (incidence ratio: 2.48 [95% CI: 1.42-4.32]). There was no increased risk for eczema, rhinitis, or atopic sensitization.
CONCLUSIONS. The rs7216389 SNP at the 17q12-q21 locus was associated with increased risk of asthma, asthma exacerbations, and bronchial hyperresponsiveness. However, it was not associated with any increased risk of atopic sensitization, eczema, or rhinitis. REVIEWER COMMENTS. This particular polymorphism was shown previously to be associated with increased risk for developing asthma. The data from this study describe the clinical phenotype associated with this SNP in a population of infants and young children at increased risk for asthma. It seems to confer a specific risk for asthma without increased atopy. This study was performed with a selected population at high risk for asthma, and future research will need to determine whether these findings are replicable in the general population. 
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
Brehm JM, Celedó n JC, Soto-Quiros ME, et al. CONCLUSIONS. Vitamin D deficiency is relatively frequent in Costa Rican children, and lower levels are associated with increased markers of allergy and asthma severity.
REVIEWER COMMENTS. Maternal vitamin D intake during pregnancy has been inversely associated with asthma symptoms in early childhood. However, no study has examined the relationship between measured vitamin D levels and markers of asthma severity in childhood. This study found an association between reduced vitamin D levels and increased markers of allergy and asthma severity in a population of Costa Rican children with asthma. Additional study of this topic using an unselected birth cohort, a case-control approach, or a clinical trial of vitamin D supplementation would be a preferable next step. Also of note, although the authors used the current standard "normal" lower threshold to define vitamin D deficiency, there is substantial debate about what the appropriate lower limit should be. METHODS. The authors examined the role of TH17 cells in asthma by using a mouse model in which severe combined immunodeficient (SCID) mice were challenged with ovalbumin. On day 0, ovalbumin-specific TH2 or TH17 cells were adoptively transferred into the SCID mice. The SCID mice were challenged with ovalbumin for 3 consecutive days after cell transfer. Mice were treated with dexamethasone or phosphate-buffered saline (control) before cell transfer on day 0 and before ovalbumin challenge on day 2. In a separate experiment, wild-type mice and interleukin 17 (IL-17) receptor-null mice underwent the same protocol.
RESULTS. Transfer of ovalbumin-specific TH2 or TH17 cells into the SCID mice, followed by ovalbumin challenge, resulted in specific cellular influx into the airways and airway hyperreactivity (AHR). TH2 cell reconstitution resulted in airway inflammation that consisted mostly of eosinophils and lymphocytes and was sensitive to dexamethasone. TH17 cell reconstitution resulted in a primarily neutrophilic airway response that was resistant to dexamethasone. Adoptive transfer of ovalbumin-specific TH2 or TH17 cells, followed by ovalbumin challenge, resulted in AHR in both cases, but the AHR was sensitive to dexamethasone in the mice reconstituted with TH2 cells and not in the mice reconstituted with TH17 cells. The inflammatory and cellular responses associated with TH17 cell transfer were mediated primarily by IL-17, because IL-17 receptor-knockout mice did not develop airway neutrophilia after adoptive transfer of ovalbumin-specific TH17 cells, followed by ovalbumin challenge.
CONCLUSIONS. Reconstitution of SCID mice with TH17 cells in a model of antigen-induced airway inflammation leads to airway neutrophilia and AHR. TH17 cellmediated neutrophil influx into the airways and AHR are resistant to dexamethasone treatment.
REVIEWERS COMMENTS. Asthma is a significant cause of morbidity and death in the pediatric population, and steroidresistant asthma is a particularly challenging asthma phenotype to manage. This study provides insight into a possible mechanism of steroid-resistant asthma, involving neutrophil recruitment into the lung tissues by TH17 cells in an IL-17-dependent pathway. Future research should be directed at determining whether the findings in this mouse model are applicable to humans and identifying patients with this asthma phenotype. If these findings prove applicable to humans, then TH17 celland IL-17-specific therapies may prove useful for patients with steroid-resistant asthma. 
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